Back
Vera Therapeutics 10K Form
Sell
17
VERA
Vera Therapeutics
Last Price:
$42.68
Seasonality Move:
28.97%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive VERA News And Ratings
See the #1 stock for the next 7 days that we like better than VERA
VERA Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-37.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $5.25 |
| Price / Book: | 9.31 |
Profitability
| EPS (TTM): | -2.61000 |
|---|---|
| Net Income (TTM): | $-134.4M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Vera Therapeutics Earnings Forecast
Key Vera Therapeutics Financial Ratios
-
The Interest Expense is -3.94% of Operating Income.
-
Per Share Earnings over the last 5 years have been positive in 2 years.
Vera Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | VERA |
| Website: | veratx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
VERA Technical Analysis vs Fundamental Analysis
Sell
17
Vera Therapeutics (VERA)
is a Sell
Is Vera Therapeutics a Buy or a Sell?
-
Vera Therapeutics stock is rated a SellThe current Vera Therapeutics [VERA] share price is $42.48. The Score for VERA is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.